HealthTab(TM) to Expand Across North East London

Executive Summary

• Avricore Health announced plans to expand its HealthTab™ point‑of‑care testing platform to an additional 70 community pharmacy sites in North East London.
• The rollout builds on a successful NHS‑linked cardiovascular programme delivered with Barts Health NHS Trust and has attracted national media coverage (BBC News).
• Expansion underscores Avricore’s strategic focus on the UK market and demonstrates scalability of its integrated POCT solution within complex NHS environments.

Key Details

• Expansion Scope: Deployment to 70 new community pharmacy locations in North East London, scheduled for “the coming weeks.”
• Program Background: Existing HealthTab™ cardiovascular programmes are linked to the NHS and were implemented in collaboration with Barts Health NHS Trust.
• Strategic Rationale: Strong pharmacy engagement, rising clinical demand, and alignment with NHS priorities to shift care from hospitals to community settings.
• Platform Highlights:
• Turnkey POCT solution combining instruments, cloud software, standardized workflows, training, and support.
• Secure cloud‑based platform integrates analyzers, patient results, and QC data for real‑time analytics and public‑health reporting.
• Quality Assurance: Partnership with CEQAL Inc., a CDC Cholesterol Reference Method Laboratory Network member, providing centralized lot monitoring, internal QC, external quality‑assessment events, and expert oversight.
• CEO Quote: Rodger Seccombe emphasized the programme’s role in setting new standards for point‑of‑care testing delivery through community pharmacies while meeting NHS clinical and governance expectations.

Notable Quotes

“This programme is helping to set a new standard for how point‑of‑care testing can be delivered effectively and responsibly through community pharmacies, while meeting the clinical and governance expectations of the NHS,” – Rodger Seccombe, CEO, Avricore Health